Engitix Therapeutics
Melissa Palmer is a renowned hepatologist and experienced biopharmaceutical executive, currently the Head of Liver Disease Development at Takeda. She worked for ~25 years as a hepatologist before moving to Kadmon Pharmaceuticals then Shire. She has a BA from Columbia and trained in Medicine and Hepatology at Mount Sinai Medical School.
This person is not in the org chart
This person is not in any offices